Dr. Lal PathLabs concluded FY26 with robust growth, reporting Rs. 2,763 crore in annual revenue, a 12.2% year-on-year increase. Q4 FY26 revenue reached Rs. 703 crore, up 16.6%, fueled by strong sample volume growth. The company successfully executed its expansion plan with 14 new labs and over 1,100 new collection centers. Management reaffirmed an early to mid-teens revenue growth trajectory for FY27, supported by broad-based performance across its core and emerging markets.
Financial Highlights
The company delivered a resilient performance in FY26, achieving a full-year revenue of Rs. 2,763 crore. The Q4 FY26 performance was particularly strong, with revenue growing 16.6% to Rs. 703 crore compared to the same period in the previous year. Full-year EBITDA stood at Rs. 752 crore with a margin of 27.2%. After adjusting for exceptional items, the FY26 EBITDA margin reached 28.3%, highlighting operational efficiency despite significant investments in network expansion.
Strategic Growth and Infrastructure
Dr. Lal PathLabs remains focused on deepening its market penetration. In FY26, the company successfully added 14 new labs and over 1,100 collection centers. A key highlight was the launch of Sovaaka, an AI-powered Precision Health Screening service, marking the company’s entry into the premium wellness space. The preventive healthcare brand, Swasthfit, continued to perform well, contributing 27% to total revenue.
Future Outlook and Investments
Looking toward FY27, leadership projects revenue growth in the early to mid-teens. To support this, the company has allocated a capex budget of Rs. 100 crore to Rs. 120 crore for the upcoming fiscal year. These funds will be directed toward maintaining existing infrastructure, opening 12 to 15 additional labs, and enhancing precision diagnostic capabilities. The company is also exploring inorganic growth opportunities, recently acquiring Shahbazkers in Mumbai for Rs. 20 crore to strengthen its presence in key micro-markets within the West region.
Shareholder Returns
Reflecting confidence in the business, the Board of Directors has approved a final dividend of Rs. 4 per share, bringing the total dividend for the year to Rs. 20.5 per share. This follows the 1:1 bonus issue completed earlier in the fiscal year.
Source: BSE
